Clinical Trial Update: Impact of Cannabinoids on Menopause Symptoms [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the impact of cannabinoids on menopause-related symptoms. The study is currently recruiting at Washington State University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Perimenopause

Drugs mentioned

• Cannabinoids (unspecified) (cannabinoids)

Snippet

Sponsor: Washington State University | Conditions: Perimenopause, Menopause | Phase 2 | Status: RECRUITING